New Provenance Everlasting Holdings Limited (HKG:2326)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	211	211	211	253	274	295
Market Cap Growth	-	-	-16.67%	-7.69%	-7.14%	7.69%
Enterprise Value	198	200	207	256	283	304
Last Close Price	0.01	0.01	0.01	0.01	0.01	0.01
PE Ratio	-	-	-	137.36	-	-
PS Ratio	0.45	0.45	0.24	0.13	1.05	0.49
PB Ratio	0.56	0.56	0.49	0.52	0.53	0.58
P/TBV Ratio	0.55	0.55	0.48	0.51	0.52	0.57
P/FCF Ratio	-	-	-	31.00	32.42	-
P/OCF Ratio	30.51	30.51	165.37	22.65	21.84	-
EV/Sales Ratio	0.42	0.43	0.24	0.14	1.08	0.51
EV/EBITDA Ratio	-	-	-	46.59	368.25	88.75
EV/EBIT Ratio	-	-	-	87.89	-	-
EV/FCF Ratio	-55.98	-	-	31.37	33.50	-
Debt / Equity Ratio	-	-	0.01	0.01	0.03	0.04
Debt / EBITDA Ratio	-	-	-	0.58	2.43	1.96
Debt / FCF Ratio	-	-	-	0.80	1.97	-
Asset Turnover	0.88	0.88	0.73	1.55	0.33	0.68
Inventory Turnover	13.84	13.84	23.93	36.29	5.70	17.77
Quick Ratio	0.90	0.90	1.18	1.06	1.25	1.29
Current Ratio	3.46	3.46	3.78	1.34	6.52	2.03
Return on Equity (ROE)	-11.49%	-11.49%	-6.85%	0.27%	-1.06%	-3.02%
Return on Assets (ROA)	-3.71%	-3.71%	-1.71%	0.15%	-0.36%	-0.57%
Return on Capital (ROIC)	-4.91%	-4.91%	-4.39%	0.35%	-0.55%	-1.01%
Return on Capital Employed (ROCE)	-	-	-	0.60%	-	-
Earnings Yield	-21.76%	-21.76%	-14.60%	0.73%	-1.99%	-12.84%
FCF Yield	-1.68%	-1.68%	-0.34%	3.23%	3.08%	-50.31%

Updated Dec 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.